Literature DB >> 816976

Therapy of neutropenic rats infected with Pseudomonas aeruginosa.

R M Lumish, C W Norden.   

Abstract

Rats made profoundly neutropenic with cyclophosphamide were injected with 100 or 1,000 50% lethal doses of a strain of Pseudomonas aeruginosa suspended in mucin. Rats were treated for 24, 48, or 72 hr with thrice daily intramuscular administration of carbenicillin (400 mg/kg), gentamicin (10 mg/kg), both of these agents at the same doses, or saline. One hour after injection of antibiotics, the mean bactericidal titers in serum were 1:4.7, 1:21., and 1:8.6 for rats receiving carbenicillin, gentamicin, and a combination of the two agents, respectively. Combination chemotherapy produced a greater reduction in mortality rate than did either agent alone for both inoculum sizes and for all three durations of therapy. Gentamicin was at least as effective as carbenicillin regardless of inoculum size or duration of therapy. Fourfold or greater increases in minimal inhibitory concentrations of P. aeruginosa were seen in 54% of postmortem blood culture isolates from animals treated with carbenicillin, in 15% from rats treated with gentamicin, and in none from animals receiving both agents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816976     DOI: 10.1093/infdis/133.5.538

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Combination therapy as a tool to prevent emergence of bacterial resistance.

Authors:  J W Mouton
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 2.  In vivo antibiotic synergism: contribution of animal models.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 3.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.

Authors:  I Braveny; K Machka; D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

5.  Antimicrobial therapy of experimental group B streptococcal infection in mice.

Authors:  A Deveikis; V Schauf; M Mizen; L Riff
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

6.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

7.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.

Authors:  L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

9.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

10.  Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.

Authors:  M W Kunst; H Mattie; R van Furth
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.